Pharmacological treatment after acute coronary syndrome : Baseline clinical characteristics and gender differences in a population-based cohort study
Sotorra Figuerola, Gerard 
(Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
Ouchi, Dan 
(Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
Garcia-Sangenis, Ana 
(Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
Giner-Soriano, Maria 
(Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
Morros, Rosa 
(Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Data: |
2021 |
Resum: |
To describe baseline socio-demographic and clinical characteristics and drugs prescribed for secondary prevention after a first episode of ACS and to assess differences between men and women. PHC in Catalonia. Data source: SIDIAP (Information System for Research in Primary Care). Patients who suffered an ACS during 2009-2016 and followed-up in PHC centres of the Catalan Health Institute in Catalonia. Not applicable. Socio-demographic and clinical characteristics at baseline: sex, age, socioeconomic index, toxic habits, comorbidities, study drugs (prescribed for cardiovascular secondary prevention: antiplatelets, betablockers, statins, drugs acting on the renin-angiotensin system) and comedications. 8071 patients included, 71. 3% of them were men and 80. 2% had an acute myocardial infarction. Their mean age was 65. 3 and women were older than men. The most frequent comorbidities were hypertension, dyslipidaemia and diabetes and they were more common in women. Antiplatelets (91. 3%) and statins (85. 7%) were the study drugs most prescribed. The uses of all comedications were significantly higher in women, except for nitrates. The combination of four study groups was initially prescribed in 47. 7% of patients and combination of beta-blockers, statins and antiplatelets was prescribed in 18. 4%. More men than women received all recommended pharmacological groups. Women were older, had more comorbidities and received more comedications. Most patients were treated with a combination of four or three study drugs for secondary prevention. Men initiated more drug treatments for secondary prevention and dual antiplatelet therapy than women. EUPAS19017. |
Drets: |
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.  |
Llengua: |
Anglès |
Document: |
Article ; recerca ; Versió publicada |
Matèria: |
Electronic health records ;
Acute coronary syndrome ;
Drug adherence ;
Secondary prevention ;
Registros electrónicos de salud ;
Síndrome coronario agudo ;
Adherencia a la medicación ;
Prevención secundaria |
Publicat a: |
Atencion Primaria, Vol. 54 (october 2021) , ISSN 1578-1275 |
DOI: 10.1016/j.aprim.2021.102157
PMID: 34717156
El registre apareix a les col·leccions:
Articles >
Articles de recercaArticles >
Articles publicats
Registre creat el 2022-01-11, darrera modificació el 2022-07-13